Reported results
- Fourth quarter net sales were $793.2 million, with organic Net Sales down 0.6%.
- Fourth quarter Gross Margin was 39.8% on a reported basis, while Adjusted Gross Margin was 42.5%.
- Fourth quarter Diluted net earnings per common share were $0.99, and Adjusted diluted net earnings per common share were $1.37.
- Full year net sales were $2.9 billion, with organic Net sales down 1.8%.
- Full year Diluted net earnings per common share were $1.67, and Adjusted diluted net earnings per common share were $3.37.
- Full year Adjusted EBITDA was $597.3 million.
Guidance
- Fiscal 2027 organic Net Sales expected to be flat to down low single digits.
- Fiscal 2027 Adjusted EBITDA expected to be approximately $560 million to $580 million.
- Fiscal 2027 Free Cash Flow expected to increase to approximately $300 million.
- First fiscal quarter 2027 Adjusted EBITDA expected to be $105 million to $115 million.
Notes
The twelve months ended September 30, 2026 included a correction to the settlement loss of $6.8 million within Other items, net, and a primarily non-cash settlement loss on the second quarter termination of the U.K. pension plan of $33.1 million.
Price and volatility reaction
The stock moved +12.6% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -5.1 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 24.34 | 2026-11-16 |
| Close after release | 27.4 | 2026-11-17 |
| Realised move | +12.6% | close to close |
| 30d ATM IV change | -5.1 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-17 (8-K, Item 2.02). Read the original filing on sec.gov.
